Anti-glutamic acid decarboxylase (GAD) autoantibodies are a hallmark of stiff-person syndrome (SPS) and insulin-dependent diabetes mellitus (IDDM). However, patients with concurrent IDDM and SPS often manifest insulin resistance, and SPS-associated IDDM probably has heterogeneous causes. Some patients manifest IDDM associated only with high titers of anti-GAD65 caused by SPS. By contrast, other patients develop IDDM only after being treated with high-dose corticosteroids or they progress to insulin dependency following their treatment with high-dose corticosteroids. The profile of autoantibodies differs markedly between type 1 diabetes mellitus (T1DM), late-onset diabetes mellitus, and SPS-associated IDDM. Therefore, as with new-onset diabetes after transplantation (NODAT), SPS-associated IDDM should be classified as a specific diabetes entity, the pathophysiology of which requires increased attention.

Charles University 3rd Faculty of Medicine Prague Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc23016108

003      

CZ-PrNML

005      

20231026110414.0

007      

ta

008      

231013s2023 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.1016/j.tem.2023.07.005 $2 doi

035    __

$a (PubMed)37586963

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Heneberg, Petr $u Charles University, Third Faculty of Medicine, Prague, Czech Republic. Electronic address: petr.heneberg@lf3.cuni.cz

245    10

$a Diabetes in stiff-person syndrome / $c P. Heneberg

520    9_

$a Anti-glutamic acid decarboxylase (GAD) autoantibodies are a hallmark of stiff-person syndrome (SPS) and insulin-dependent diabetes mellitus (IDDM). However, patients with concurrent IDDM and SPS often manifest insulin resistance, and SPS-associated IDDM probably has heterogeneous causes. Some patients manifest IDDM associated only with high titers of anti-GAD65 caused by SPS. By contrast, other patients develop IDDM only after being treated with high-dose corticosteroids or they progress to insulin dependency following their treatment with high-dose corticosteroids. The profile of autoantibodies differs markedly between type 1 diabetes mellitus (T1DM), late-onset diabetes mellitus, and SPS-associated IDDM. Therefore, as with new-onset diabetes after transplantation (NODAT), SPS-associated IDDM should be classified as a specific diabetes entity, the pathophysiology of which requires increased attention.

650    _2

$a lidé $7 D006801

650    12

$a diabetes mellitus 1. typu $7 D003922

650    12

$a syndrom celkové ztuhlosti $7 D016750

650    12

$a diabetes mellitus 2. typu $7 D003924

650    _2

$a inzulin $7 D007328

650    _2

$a autoprotilátky $7 D001323

655    _2

$a časopisecké články $7 D016428

655    _2

$a přehledy $7 D016454

773    0_

$w MED00004567 $t Trends in endocrinology and metabolism: TEM $x 1879-3061 $g Roč. 34, č. 10 (2023), s. 640-651

856    41

$u https://pubmed.ncbi.nlm.nih.gov/37586963 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y - $z 0

990    __

$a 20231013 $b ABA008

991    __

$a 20231026110408 $b ABA008

999    __

$a ok $b bmc $g 1999933 $s 1202470

BAS    __

$a 3

BAS    __

$a PreBMC-MEDLINE

BMC    __

$a 2023 $b 34 $c 10 $d 640-651 $e 20230814 $i 1879-3061 $m Trends in endocrinology and metabolism $n Trends endocrinol. metab. $x MED00004567

LZP    __

$a Pubmed-20231013